Omeros has filed an investigational new drug application (IND) with the FDA for OMS824, the compound from its phosphodiesterase 10 (PDE10) program for schizophrenia and other cognitive disorders. OMS824 targets and inhibits an enzyme ...
Tags: new drug application, FDA, OMS824
Takeda's wholly-owned subsidiary, Takeda America Holdings and LigoCyte Pharmaceuticals have entered into a definitive agreement for Takeda to acquire LigoCyte for an upfront payment of $60m, with future contingent consideration based on the ...
US Department of Defense has granted a Congressionally Directed Medical Research Programs (CDMRP) grant to Aduro BioTech to complete the preclinical development of a new therapeutic cancer vaccine for prostate cancer. Aduro's cancer ...
Tags: Aduro, cancer vaccine platform, IND